# Malaria Treatment With Injectable ArteSunate

> **NCT01828333** · — · COMPLETED · sponsor: **Swiss Tropical & Public Health Institute** · enrollment: 350 (actual)

## Conditions studied

- Severe Malaria

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT01828333
- **Lead sponsor:** Swiss Tropical & Public Health Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2013-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01828333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01828333, "Malaria Treatment With Injectable ArteSunate". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01828333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*